Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Periodontitis prevalence and serum antibody reactivity to periodontal bacteria in primary Sjögren's syndrome: a pilot study.
Lugonja B, Yeo L, Milward MR, Smith D, Dietrich T, Chapple IL, Rauz S, Williams GP, Barone F, de Pablo P, Buckley C, Hamburger J, Richards A, Poveda-Gallego A, Scheel-Toellner D, Bowman SJ. Lugonja B, et al. Among authors: rauz s. J Clin Periodontol. 2016 Jan;43(1):26-33. doi: 10.1111/jcpe.12485. Epub 2016 Jan 23. J Clin Periodontol. 2016. PMID: 26646777
The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership.
Harman KE, Barha J, Chalmers JR, Dart JKG, Davies I, Ellis P, Grindlay D, Hampton PJ, Hill S, Hockey S, Lloyd-Lavery A, McPhee M, Murphy R, Rauz S, Setterfield JF, Thompson I, Westmoreland M, Waistell C. Harman KE, et al. Among authors: rauz s. Br J Dermatol. 2023 Sep 15;189(4):469-498. doi: 10.1093/bjd/ljad140. Br J Dermatol. 2023. PMID: 37201904 No abstract available.
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.
Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, Canavan A, Hamburger J, Richards A, Rauz S, Regan M, Gadsby K, Rigby S, Jones A, Mathew R, Mulherin D, Stevenson A, Nightingale P. Bowman SJ, et al. Among authors: rauz s. Rheumatology (Oxford). 2007 Dec;46(12):1845-51. doi: 10.1093/rheumatology/kem280. Rheumatology (Oxford). 2007. PMID: 18032543
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.
Barry RJ, Sutcliffe N, Isenberg DA, Price E, Goldblatt F, Adler M, Canavan A, Hamburger J, Richards A, Regan M, Gadsby K, Rigby S, Jones A, Mathew R, Mulherin D, Stevenson A, Nightingale P, Rauz S, Bowman SJ. Barry RJ, et al. Among authors: rauz s. Rheumatology (Oxford). 2008 Aug;47(8):1193-8. doi: 10.1093/rheumatology/ken164. Epub 2008 Jun 4. Rheumatology (Oxford). 2008. PMID: 18524804
Estimating indirect costs in primary Sjögren's syndrome.
Bowman SJ, St Pierre Y, Sutcliffe N, Isenberg DA, Goldblatt F, Price E, Hamburger J, Richards A, Rauz S, Regan M, Rigby S, Jones A, Mulherin D, Clarke AE. Bowman SJ, et al. Among authors: rauz s. J Rheumatol. 2010 May;37(5):1010-5. doi: 10.3899/jrheum.090734. Epub 2010 Apr 1. J Rheumatol. 2010. PMID: 20360188
150 results